0001104659-22-099283.txt : 20220912
0001104659-22-099283.hdr.sgml : 20220912
20220912170019
ACCESSION NUMBER: 0001104659-22-099283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220909
FILED AS OF DATE: 20220912
DATE AS OF CHANGE: 20220912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ende Eric J
CENTRAL INDEX KEY: 0001494386
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35963
FILM NUMBER: 221239129
MAIL ADDRESS:
STREET 1: C/O MATINAS BIOPHARMA HOLDINGS, INC.
STREET 2: 1545 ROUTE 206 SOUTH, SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuBase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001173281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465622433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 350 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
BUSINESS PHONE: 412-763-3350
MAIL ADDRESS:
STREET 1: 350 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
FORMER COMPANY:
FORMER CONFORMED NAME: Ohr Pharmaceutical Inc
DATE OF NAME CHANGE: 20090819
FORMER COMPANY:
FORMER CONFORMED NAME: BBM HOLDINGS, INC.
DATE OF NAME CHANGE: 20070402
FORMER COMPANY:
FORMER CONFORMED NAME: PRIME RESOURCE INC
DATE OF NAME CHANGE: 20020513
4
1
tm2225655-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-09-09
0
0001173281
NeuBase Therapeutics, Inc.
NBSE
0001494386
Ende Eric J
C/O 350 TECHNOLOGY DRIVE, FOURTH FLOOR
PITTSBURGH
PA
15219
1
0
0
0
Stock option (right to buy)
0.60
2022-09-09
4
A
0
37600
0
A
2032-09-09
Common Stock
37600
37600
D
25% of the total shares shall vest on the first anniversary of September 9, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months.
The power of attorney under which this form was signed is on file with the Commission.
/s/ Todd Branning, as attorney-in-fact for Eric J. Ende
2022-09-12